Explore the complete record of transactions filed by Susan Ringdal. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. Cumulatively, 16 disclosures have been logged. Activity tracked since 10 August 2023. The latest transaction was filed on 1 June 2026 (Vesting). Regulator: RNS (LSE). The full history is accessible without signup.
Companies and markets linked to Susan Ringdal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Susan Ringdal is a declarant linked to Hikma Pharmaceuticals PLC (XLON), where she is a PDMR. She has 16 filings in total, and across the 16 sampled filings the buy volume is EUR 118936 and the sell volume is EUR 713327, over the period from 2023-08-11 to 2026-06-05. The modal transaction nature is Vesting.